FDA's Fast Track Approval Puts Consumers at Risk
Rule 501(k) allows improvements on products to go to market without clinical trials, presenting patients with unknown dangers, explains Jeffrey Milman of Hodes Milman.
Product Liability
Legal Risk of Generic Drugs
Plaintiff's ability to recover for medication-related harm may depend on whether the presciption was filled with a name-brand drug, explains Hastings' Marsha Cohen.
FDA's Fast Track Approval Puts Consumers at Risk
sponsor spotlight
sponsor spotlight
Practice areas
- Alternative Dispute Resolution
- Antitrust & Trade Regulation
- Appellate Law
- Banking & Finance
- Biotechnology
- Civil Rights & Constitutional Law
- Consumer Protection
- Corporate & Business Law
- Corporate Governance and Compliance
- Criminal Law
- Energy & Natural Resources
- Environmental Law
- Ethics
- Family Law
- Health Law
- Insurance Law
- Intellectual Property
- International Law
- Internet and Technology Law
- Labor and Employment Law
- Litigation
- Mergers & Acquisitions
- Personal Injury
- Product Liability
- Real Estate
- Securities
- Tax
- White Collar Crime
Most Viewed Articles
- As Dewey Partners Find New Homes, Questions Mount About Old One
- Alsup to Boies: I Can Code -- Can You?
- Brown Cuts $544 Million from Court Budget
- Dewey's NorCal IP Group Breaks Off To Form Own Shop
- European Tech Companies Tap Valley Lawyers for IPOs
